• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】17576

【品名】ethyl 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]-2-oxoacetate

【CA登记号】

【 分 子 式 】C25H24ClNO3

【 分 子 量 】421.9232

【元素组成】C 71.17% H 5.73% Cl 8.4% N 3.32% O 11.38%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(XII)

A new synthesis of ML-3000 has been published: The reaction of 3-phenyl-2-propynyl chloride (I) with isobutyraldehyde (II) by means of tetrabutylammonium iodide/NaI/NaOH in toluene/water gives 2,2-dimethyl-5-phenyl-4-pentynal (III), which is condensed with glycine methyl ester by means of NaBH(OAc)3 and triethylamine in dichloromethane yielding the N-alkyl-glycine (V). The cyclization of (V) by means of pivalic acid at 150 C affords the bicyclic ketone (VI), which is condensed with diethyl oxalate (VII) by means of sodium ethoxide in ethanol giving the ethoxalyl derivative (VIII). The esterification of (VIII) with the triflic amide (IX) yields the triflate (X), which is condensed with 4-chlorophenylboronic acid (XI) by means of palladium tetrakis(triphenylphosphine) as catalyst in refluxing THF affording the compound (XII). The reduction of the oxoacetic group with tosyl hydrazide (XIII) in refluxing ethanol gives the expected acetate derivative (XIV), which is finally hydrolyzed with NaOH in hot ethanol/water.

1 Cossy, J.; Belotti, D.; Synthesis of ML-3000, an inhibitor of cyclooxygenase and 5-lipoxygenase. J Org Chem 1997, 62, 23, 7900.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17565 1-(3-chloro-1-propynyl)benzene C9H7Cl 详情 详情
(II) 13226 2-Methylpropanal; Isobutyraldehyde 78-84-2 C4H8O 详情 详情
(III) 17567 2,2-dimethyl-5-phenyl-4-pentynal C13H14O 详情 详情
(IV) 17568 methyl 2-aminoacetate C3H7NO2 详情 详情
(V) 17569 methyl 2-[(2,2-dimethyl-5-phenyl-4-pentynyl)amino]acetate C16H21NO2 详情 详情
(VI) 17570 2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-6(5H)-one C15H17NO 详情 详情
(VII) 17571 Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate 95-92-1 C6H10O4 详情 详情
(VIII) 17572 ethyl 2-(6-hydroxy-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl)-2-oxoacetate C19H21NO4 详情 详情
(IX) 17573 N-Phenyltrifluoromethanesulfonimide; Trifluoro-N-phenyl-N-[(trifluoromethyl)sulfonyl]methanesulfonamide 37595-74-7 C8H5F6NO4S2 详情 详情
(X) 17574 ethyl 2-(2,2-dimethyl-7-phenyl-6-[[(trifluoromethyl)sulfonyl]oxy]-2,3-dihydro-1H-pyrrolizin-5-yl)-2-oxoacetate C20H20F3NO6S 详情 详情
(XI) 17575 4-chlorophenylboronic acid 1679-18-1 C6H6BClO2 详情 详情
(XII) 17576 ethyl 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]-2-oxoacetate C25H24ClNO3 详情 详情
(XIII) 17577 p-Toluenesulfonyl Hydrazide; 4-methylbenzenesulfonohydrazide 1576-35-8 C7H10N2O2S 详情 详情
(XIV) 16723 ethyl 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetate C25H26ClNO2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

An alternative route to improve the yield of a previous reported synthesis of ML-3000 [Cossy, J. and Belotti, D. J Org Chem 1997, 62(23): 7900] has been reported: The reduction of the oxoacetic ester intermediate (I) can also be performed stepwise by treatment of (I) with tosylhydrazine (II), isolation of the corresponding tosylhydrazone (III), and reduction with sodium cyanoborohydride in ethanol to yield the expected acetate (IV). Finally, this compound is hydrolyzed with NaOH as already described.

1 Cossy, J.; Belotti, D.; Synthetic studies towards ML-3000 - A concise synthesis of this non-steroidal anti-inflammatory drug. Tetrahedron 1999, 55, 16, 5145.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17576 ethyl 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]-2-oxoacetate C25H24ClNO3 详情 详情
(II) 17577 p-Toluenesulfonyl Hydrazide; 4-methylbenzenesulfonohydrazide 1576-35-8 C7H10N2O2S 详情 详情
(III) 28699 ethyl 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]-2-[(Z)-2-[(4-methylphenyl)sulfonyl]hydrazono]acetate C32H32ClN3O4S 详情 详情
(IV) 16723 ethyl 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetate C25H26ClNO2 详情 详情
Extended Information